HANOVER, MD
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)IMMUNE DEFICIENCY FOUNDATION, founded in 1980, is a mid-sized nonprofit in the Medical Research sector that reported $10.1M in total revenue in fiscal year 2024. Revenue grew 13% year-over-year, indicating healthy expansion. Expenses of $9.6M left a modest 5% surplus.
THE IMMUNE DEFICIENCY FOUNDATION IMPROVES THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE FOR EVERY PERSON AFFECTED BY PRIMARY IMMUNODEFICIENCY. WE FOSTER A COMMUNITY THAT IS CONNECTED, ENGAGED, AND EMPOWERED THROUGH ADVOCACY, EDUCATION, AND RESEARCH.
IMMUNE DEFICIENCY FOUNDATION (IDF) PROVIDED EDUCATIONAL PROGRAMS AND SERVICES FOR PATIENTS AND FAMILIES LIVING WITH PRIMARY IMMUNODEFICIENCIES (PI). IN 2024, APPROXIMATELY 30,700 INDIVIDUALS WERE...
IMMUNE DEFICIENCY FOUNDATION (IDF) PROVIDED EDUCATIONAL PROGRAMS AND SERVICES FOR PATIENTS AND FAMILIES LIVING WITH PRIMARY IMMUNODEFICIENCIES (PI). IN 2024, APPROXIMATELY 30,700 INDIVIDUALS WERE PROVIDED WITH EDUCATION AND SUPPORT THROUGH PUBLICATIONS, WEBINARS, VIDEOS AND PODCAST EPISODES, IDF GET CONNECTED GROUP MEETINGS, TEEN AND YOUNG ADULT ACTIVITIES AND THE IDF PI CONFERENCE. THERE WERE 997 ATTENDEES AT THE PI CONFERENCE (THE FIRST IN-PERSON PI CONFERENCE SINCE 2019), WHERE IDF DEBUTED OUR DOCUMENTARY, "COMPROMISED: LIFE WITHOUT IMMUNITY". IDF PROVIDED MORE THAN 265 HOTEL ROOM AND FLIGHT SCHOLARSHIPS FOR PI CONFERENCE ATTENDEES. MORE THAN 1.3 MILLION IDF WEBSITE SESSIONS WERE ACCESSED FOR INFORMATION, EVENTS, PODCASTS AND SUPPORT AND MORE THAN 625 IMMUNE SYSTEM SELF- ASSESSMENTS WERE SUBMITTED VIA THE WEBSITE.
THE PI COMMUNITY TURNS TO IDF FOR INDIVIDUAL ASSISTANCE INCLUDING BUT NOT LIMITED TO ANSWERING INSURANCE QUESTIONS, LOCATING A SPECIALIST IN THEIR AREA, FINDING TREATMENT INFORMATION, AND LEARNING...
THE PI COMMUNITY TURNS TO IDF FOR INDIVIDUAL ASSISTANCE INCLUDING BUT NOT LIMITED TO ANSWERING INSURANCE QUESTIONS, LOCATING A SPECIALIST IN THEIR AREA, FINDING TREATMENT INFORMATION, AND LEARNING MORE ABOUT THEIR DIAGNOSIS. IDF'S PATIENT ADVOCACY SPECIALISTS PROVIDED ANSWERS TO OVER 1,900 QUESTIONS ON 300 DIFFERENT TOPICS FROM INDIVIDUALS SEEKING EDUCATION, INFORMATION, AND ASSISTANCE. IDF ALSO WORKS AT THE FEDERAL AND STATE LEVELS TO EDUCATE LAWMAKERS AND THE PUBLIC ABOUT ISSUES THAT IMPACT THOSE WHO ARE IMMUNOCOMPROMISED. A STRONG VOLUNTEER GRASSROOTS ADVOCACY NETWORK, INCLUDING HEALTH ACCESS ADVOCATE VOLUNTEERS, INFORM POLICYMAKERS ABOUT ISSUES AFFECTING THOSE WITH PI. IN 2024, 850 INDIVIDUALS MET WITH AND SENT MORE THAN 2,700 LETTERS AND MESSAGES TO LEGISLATORS AND EXECUTIVE OFFICIALS TO ENSURE THAT PEOPLE WITH PI CAN LIVE HEALTHY AND PRODUCTIVE LIVES WITH EXCELLENT TREATMENT OPTIONS AND ACCESS TO THE MOST APPROPRIATE HEALTHCARE AVAILABLE.
TO IMPROVE THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF THOSE AFFECTED BY PI, IDF HAS SEVERAL INITIATIVES TO PROVIDE RESOURCES DIRECTLY TO THE MEDICAL COMMUNITY, INCLUDING EXHIBITING AT TEN...
TO IMPROVE THE DIAGNOSIS, TREATMENT, AND QUALITY OF LIFE OF THOSE AFFECTED BY PI, IDF HAS SEVERAL INITIATIVES TO PROVIDE RESOURCES DIRECTLY TO THE MEDICAL COMMUNITY, INCLUDING EXHIBITING AT TEN MEDICAL CONFERENCES IN 2024, PROVIDING INFORMATION AND RESOURCES TO HEALTHCARE PROFESSIONALS, AND ADMINISTERING A CONSULTING IMMUNOLOGIST PROGRAM THAT ALLOWS CLINICIANS TO CONSULT WITH AN EXPERT CLINICAL IMMUNOLOGIST ABOUT PATIENT-SPECIFIC QUESTIONS TO OBTAIN VALUABLE DIAGNOSTIC, TREATMENT, AND DISEASE MANAGEMENT INFORMATION. IDF CONDUCTS NATIONAL SURVEYS AND FOCUS GROUPS OF PATIENTS, PHYSICIANS, AND OTHER HEALTHCARE PROFESSIONALS, BUILDING A COLLECTION OF QUANTIFIABLE DATA RELATED TO PRIMARY IMMUNODEFICIENCY. IN 2024, OVER 1,000 INDIVIDUALS PARTICIPATED IN AN IDF PATIENT SURVEY TO GATHER DATA ON IG TREATMENT. THERE WERE FOUR PUBLICATIONS IN 2024 USING USIDNET DATA. BECAUSE MEDICAL RESEARCH IS A PRIORITY, THE IDF RESEARCH GRANT PROGRAM FUNDED FOUR RESEARCH GRANTS FOR PI RELATED RESEARCH IN 2024, TOTALING OVER 159,000.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $10,131,702 | $8,985,857 | +0.1% |
| Expenses | $9,612,798 | $7,402,254 | +0.3% |
| Net Income | $518,904 | $1,583,603 | -0.7% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JOREY BERRY | PRESIDENT & | 40.00 |
Officer
|
$291,976 | $55,291 | $347,267 |
| AIMEE SIMPSON | VP INSTITUTI | 40.00 |
Highest
|
$157,876 | $20,059 | $177,935 |
| SARAH ROSE | CFO | 40.00 |
Officer
|
$147,965 | $24,842 | $172,807 |
| BRIAN LLOYD | CTO | 40.00 |
Highest
|
$143,863 | $28,724 | $172,587 |
| TAMMY BLACK | VP COMMUNICA | 40.00 |
Highest
|
$151,684 | $19,050 | $170,734 |
| LYNN ALBIZO | VP PUBLIC PO | 40.00 |
Highest
|
$142,625 | $22,962 | $165,587 |
| CHRISTOPHER DUCKETT | DIRECTOR OF | 40.00 |
Highest
|
$126,700 | $29,637 | $156,337 |
| JASON ANGELOS | FINANCE CHAI | 1.00 |
Director
|
$0 | $0 | $0 |
| PETE ATHERTON | FUTURES CHAI | 1.00 |
Director
|
$0 | $0 | $0 |
| COLLEEN DANSEREAU | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| CHARLENE GRABOWSKI | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| SETH KAUFMAN | BOARD VICE C | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| KATE SULLIVAN MD | MAC CHAIR | 1.00 |
Director
|
$0 | $0 | $0 |
| ADRIAN MOLLO | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| ANDY ROBINS | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| STELLA SAFO | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| TRACY A SHAW | BOARD CHAIR | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SONIA VOHNOUT | BOARD SECRET | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| PETER WANG | TRUSTEE | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $10,131,702 | $9,612,798 | $18,802,131 | $518,904 |
| 2023 | $8,985,857 | $7,402,254 | $17,355,217 | $1,583,603 |
| 2022 | $8,852,448 | $7,936,471 | $14,567,941 | $915,977 |
| 2021 | $9,938,471 | $8,023,615 | $14,287,227 | $1,914,856 |
| 2020 | $6,782,778 | $6,532,541 | $12,389,861 | $250,237 |
| 2019 | $9,460,017 | $8,601,612 | $11,518,997 | $858,405 |
| 2018 | $6,350,758 | $6,409,783 | $9,299,139 | $-59,025 |
Compare IMMUNE DEFICIENCY FOUNDATION with other nonprofits in Maryland and across the country.